Cargando…
P321: TNF-MEDIATED CELL DEATH: AN ACTIONABLE TARGET FOR IMMUNOTHERAPY IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428464/ http://dx.doi.org/10.1097/01.HS9.0000968196.97465.b3 |
| _version_ | 1785090475895554048 |
|---|---|
| author | Dourthe, Marie-Emilie Lengline, Etienne Charbonnier, Guillaume Latiri, Mehdi Saji, Chaimae Cieslak, Agata Simonin, Mathieu Ifrah, Norbert Dombret, Hervé Hermine, Olivier Boissel, Nicolas Baruchel, André Ghysdael, Jacques Macintyre, Elizabeth Tran-Quang, Christine Andrieu, Guillaume Asnafi, Vahid |
| author_facet | Dourthe, Marie-Emilie Lengline, Etienne Charbonnier, Guillaume Latiri, Mehdi Saji, Chaimae Cieslak, Agata Simonin, Mathieu Ifrah, Norbert Dombret, Hervé Hermine, Olivier Boissel, Nicolas Baruchel, André Ghysdael, Jacques Macintyre, Elizabeth Tran-Quang, Christine Andrieu, Guillaume Asnafi, Vahid |
| author_sort | Dourthe, Marie-Emilie |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428464 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104284642023-08-17 P321: TNF-MEDIATED CELL DEATH: AN ACTIONABLE TARGET FOR IMMUNOTHERAPY IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA Dourthe, Marie-Emilie Lengline, Etienne Charbonnier, Guillaume Latiri, Mehdi Saji, Chaimae Cieslak, Agata Simonin, Mathieu Ifrah, Norbert Dombret, Hervé Hermine, Olivier Boissel, Nicolas Baruchel, André Ghysdael, Jacques Macintyre, Elizabeth Tran-Quang, Christine Andrieu, Guillaume Asnafi, Vahid Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428464/ http://dx.doi.org/10.1097/01.HS9.0000968196.97465.b3 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Dourthe, Marie-Emilie Lengline, Etienne Charbonnier, Guillaume Latiri, Mehdi Saji, Chaimae Cieslak, Agata Simonin, Mathieu Ifrah, Norbert Dombret, Hervé Hermine, Olivier Boissel, Nicolas Baruchel, André Ghysdael, Jacques Macintyre, Elizabeth Tran-Quang, Christine Andrieu, Guillaume Asnafi, Vahid P321: TNF-MEDIATED CELL DEATH: AN ACTIONABLE TARGET FOR IMMUNOTHERAPY IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA |
| title | P321: TNF-MEDIATED CELL DEATH: AN ACTIONABLE TARGET FOR IMMUNOTHERAPY IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA |
| title_full | P321: TNF-MEDIATED CELL DEATH: AN ACTIONABLE TARGET FOR IMMUNOTHERAPY IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA |
| title_fullStr | P321: TNF-MEDIATED CELL DEATH: AN ACTIONABLE TARGET FOR IMMUNOTHERAPY IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA |
| title_full_unstemmed | P321: TNF-MEDIATED CELL DEATH: AN ACTIONABLE TARGET FOR IMMUNOTHERAPY IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA |
| title_short | P321: TNF-MEDIATED CELL DEATH: AN ACTIONABLE TARGET FOR IMMUNOTHERAPY IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA |
| title_sort | p321: tnf-mediated cell death: an actionable target for immunotherapy in t-cell acute lymphoblastic leukemia |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428464/ http://dx.doi.org/10.1097/01.HS9.0000968196.97465.b3 |
| work_keys_str_mv | AT dourthemarieemilie p321tnfmediatedcelldeathanactionabletargetforimmunotherapyintcellacutelymphoblasticleukemia AT lenglineetienne p321tnfmediatedcelldeathanactionabletargetforimmunotherapyintcellacutelymphoblasticleukemia AT charbonnierguillaume p321tnfmediatedcelldeathanactionabletargetforimmunotherapyintcellacutelymphoblasticleukemia AT latirimehdi p321tnfmediatedcelldeathanactionabletargetforimmunotherapyintcellacutelymphoblasticleukemia AT sajichaimae p321tnfmediatedcelldeathanactionabletargetforimmunotherapyintcellacutelymphoblasticleukemia AT cieslakagata p321tnfmediatedcelldeathanactionabletargetforimmunotherapyintcellacutelymphoblasticleukemia AT simoninmathieu p321tnfmediatedcelldeathanactionabletargetforimmunotherapyintcellacutelymphoblasticleukemia AT ifrahnorbert p321tnfmediatedcelldeathanactionabletargetforimmunotherapyintcellacutelymphoblasticleukemia AT dombretherve p321tnfmediatedcelldeathanactionabletargetforimmunotherapyintcellacutelymphoblasticleukemia AT hermineolivier p321tnfmediatedcelldeathanactionabletargetforimmunotherapyintcellacutelymphoblasticleukemia AT boisselnicolas p321tnfmediatedcelldeathanactionabletargetforimmunotherapyintcellacutelymphoblasticleukemia AT baruchelandre p321tnfmediatedcelldeathanactionabletargetforimmunotherapyintcellacutelymphoblasticleukemia AT ghysdaeljacques p321tnfmediatedcelldeathanactionabletargetforimmunotherapyintcellacutelymphoblasticleukemia AT macintyreelizabeth p321tnfmediatedcelldeathanactionabletargetforimmunotherapyintcellacutelymphoblasticleukemia AT tranquangchristine p321tnfmediatedcelldeathanactionabletargetforimmunotherapyintcellacutelymphoblasticleukemia AT andrieuguillaume p321tnfmediatedcelldeathanactionabletargetforimmunotherapyintcellacutelymphoblasticleukemia AT asnafivahid p321tnfmediatedcelldeathanactionabletargetforimmunotherapyintcellacutelymphoblasticleukemia |